Developing an EEG Probe for Studying and Modulating Cognitive Control

The investigators will perform a double blind, randomized, sham controlled, crossover study design to assess effects of tES, tsDCS and sham stimulation on the performance during a cognitive control task. The working Hypothesis is tsDCS and/or tES will enhance frontal theta oscillations as recorded on EEGs and improve task performance compared to sham stimulation.

Results from this project can potentially lead to the development of a new research tool for assessing neuromodulation strategies to treat mental disorders and their comorbidities. It will also uncover the neural correlates of cognitive deficits in PSD and provide feasible biomarkers associated with treatment response in support of a larger clinical.

Inclusion criteria

• Subjects will include both male and female of age over 18 years and a BMI of 18-35 Kg/mts2 who have experienced stroke.
• Moderately depressed, MADRS:18-28, PHQ9: 10-20 and/or experiencing cognitive impairments after stroke

Exclusion criteria

• Current or lifetime bipolar disorder or schizophrenia diagnosis;
• current (past month): PTSD, psychotic or substance use disorder (nicotine and caffeine allowed);
• significant risk of suicide according to CSSRS or clinical judgment, or suicidal behavior in the past year:
• current chronic severe pain conditions;
• current chronic use of: opioids analgesics, medications that affect blood pressure or drugs with significant autonomic effects (stimulants and antipsychotics allowed if dose stable for 1 month);
• skin lesions on electrode placement region;
• implanted electrical medical devices;
• Pregnancy;
• suspected IQ<80, and 10) any other clinically relevant reason as judged by the clinician.